- Home
- GDYN vs JANX Comparison
GDYN vs JANX Comparison
Compare GDYN & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDYN | JANX |
|---|---|---|
| Founded | 2006 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GDYN | JANX |
|---|---|---|
| Price | $13.22 | $11.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 18 |
| Target Price | $13.00 | ★ $33.14 |
| AVG Volume (30 Days) | ★ 1.9M | 974.4K |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 120.00 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $111,283,000.00 | $10,000,000.00 |
| Revenue This Year | $6.93 | $174.21 |
| Revenue Next Year | $9.86 | N/A |
| P/E Ratio | $148.61 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.11 | $11.45 |
| 52 Week High | $14.14 | $35.34 |
Technical Indicators
Market Signals| Indicator | GDYN | JANX |
|---|---|---|
| Relative Strength Index (RSI) | 69.97 | 29.05 |
| Support Level | $5.57 | N/A |
| Resistance Level | $14.02 | $14.47 |
| Average True Range (ATR) | 0.81 | 1.31 |
| MACD | 0.12 | -0.68 |
| Stochastic Oscillator | 83.79 | 3.35 |
Price Performance
Historical ComparisonAbout GDYN Grid Dynamics Holdings Inc.
Grid Dynamics Holdings Inc is a provider of technology consulting, platform and product engineering, and advanced analytics services. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.